Important prognostic histological parameters for patients with invasive ductal carcinoma of the pancreas

Cancer Science

Volumn 96, Issue 12, 2005, Pages 858-865

  Mitsunaga, Shuichi ^a,c,d   Hasebe, Takahiro ^a   Iwasaki, Motoki ^b   Kinoshita, Taira ^c   Ochiai, Atsushi ^a   Shimizu, Nobuyoshi ^d  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NERVE PLEXUS; PANCREAS CARCINOMA; PANCREAS RESECTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; TREATMENT OUTCOME; TUMOR NECROSIS; TUMOR VOLUME;

AGED; CARCINOMA, DUCTAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 30344461873     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2005.00128.x     Document Type: Article

References (32)

1. Takahashi H, Oda T, Hasebe T et al. Biologically different subgroups of invasive ductal carcinoma of the pancreas: Dpc4 status according to the ratio of intraductal carcinoma components. Clin Cancer Res 2004; 10: 3772-9.
2. Ebrahimi B, Tucker SL, Li D, Abbruzzese JL, Kurzrock R. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. Cancer 2004; 15: 2727-36.
3. Schlieman MG, Fahy BN, Ramsamooj R, Beckett L, Bold RJ. Incidence, mechanism and prognostic value of activated AKT in pancreas cancer. Br J Cancer 2003; 89: 2110-15.
4. Grutzmann R, Luttges J, Sipos B et al. ADAM9 expression in pancreatic cancer is associated with tumor type and is a prognostic factor in ductal adenocarcinoma. Br J Cancer 2004; 90: 1053-8.
5. Nakatsura T, Hasebe T, Tsubono Y et al. Histological prognostic parameters for adenocarcinoma of the pancreatic head: proposal for a scoring system for prediction of outcome. J Hep Bil Pancr Surg 1997; 4: 441-8.
6. Watanabe I, Hasebe T, Sasaki S et al. Advanced pancreatic ductal cancer: fibrotic focus and beta-catenin expression correlate with outcome. Pancreas 2003; 26: 326-33.
7. Geer JR, Brennan FM. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993; 165: 68-73.
8. Sohn TA, Yeo CJ, Cameron JL et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastroint Surg 83: 567-79.
9. Lim EJ, Chien WM, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma. Ann Surg 2003; 237: 74-85.
10. Kuhlmann KFD, de Castro SMM, Wesseling JG et al. Surgical treatment of pancreatic adenocarcinoma: actual survival and prognostic factors in 343 patients. Eur J Surg 2004; 40: 549-58.
11. Luttges J, Schemn S, Vogel I, Hedderich J, Kremer B, Kloppel G. The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation. J Pathol 2000; 191: 154-61.
12. Takai S, Satoi S, Toyokawa H et al. Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience. Pancreas 2003; 26: 243-9.
13. Takahashi S, Hasebe T, Oda T et al. Extra-tumor perineural invasion predicts postoperative development of peritoneal dissemination in pancreatic ductal adenocarcinoma. Anticancer Res 2001; 21: 1407-12.
14. Adsay NV, Basturk O, Bonnett M et al. A proposal for a new and more practical grading scheme for pancreatic ductal adenocarcinoma. Am J Surg Parhol 2005; 29: 724-33.
15. Hamilton RS, Aaltonen AL, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumors of the Digestive System. Lyon: IARC Press, 2000.
16. Sobin HL, Wiitekind C, eds. TNM Classification of Malignant Tumors, 6th edn. New York: Wiley-Liss, 2002.
17. Japan Pancreas Society. The Classification of Pancreatic Carcinoma, 1st English edn. Tokyo: Kanehara, 1996.
18. Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974; 111: 58-64.
19. Peto R, Pike MC, Armitage P. Design and analysis of randomized clinical trial requiring prolonged observation of each patient: Analysis and examples. Br J Cancer 35: 1-39.
20. Cox DR. Regression models and life-tables. J R Stat Soc 1972; 34: 187-220.
21. Kaplan EL, Meiyer P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
22. Gilchrist KW, Gray R, Fowble B, Tormey DC, Taylor SG. Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 eastern cooperative oncology group patients. J Clin Oncol 1993; 11: 1929-35.
23. Hockel M, Vaupel P. Tumor hypoxia: definition and current clinical, biologic, and molecular aspect. J Natl Cancer Inst 2001; 93: 266-76.
24. Tripodi SA, Del Vecchio MT, Supuran CT et al. Redox state and carbonic anhydrase isozyme IX expression in human renal cell carcinoma: biochemical and morphological investigations. J Enzyme Inhib Med Chem 2004; 19: 287-91.
25. Koong AC, Mehta VK, Le QT et al. Pancreatic tumors show high levels of hypoxia. Int J Radiation Oncol Biol Phys 2000; 48: 919-22.
26. Buchler P, Reber HA, Lavey RS et al. Tumor hypoxia correlates with metastatic tumor growth of pancreatic cancer in an orthotopic murine model. J Surg Res 2004; 120: 295-303.
27. Kivela AJ, Parkkila S, Saarnio J et al. Expression of transmembrane carbonic anhydrase isoenzymes IX and XII in normal human pancreas and pancreatic tumours. Histochem Cell Biol 2000; 114: 197-204.
28. Shibaji T, Nagao M, Ikeda N et al. Prognostic significance of HIF-1 alpha overexpression in human pancreatic cancer. Anticancer Res 2003; 23: 4721-7.
29. Sipos B, Weber D, Ungefroren H et al. Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study. Int J Cancer 2002; 102: 592-600.
30. Pour PM, Egami H, Takayama Y. Patterns of growth and metastases of induced pancreatic cancer in relation to the prognosis and its clinical implications. Gastroenterology 1991; 100: 529-36.
31. Furukawa H, Takayasu K, Mukai K, Inoue K, Kosuge T, Ushio K. Computed tomography of pancreatic adenocarcinoma: comparison of tumor size measured by dynamic computed tomography and histopathologic examination. Pancreas 1996; 13: 231-5.
32. Demachi H, Matsui O, Kobayashi S et al. Histological influence on contrast-enhanced CT of pancreatic ductal adenocarcinoma. J Comput Assist Tomogr 1997; 21: 980-5.